Episode notes
This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, about treating chronic low back pain, and with Monika Paulė, CEO and co-founder of Caszyme.
Interview time stamps:
Times: 01:40 Caszyme
16:04 Persica Pharmaceuticals
Persica Pharmaceuticals
Persica is developing a potentially transformative non-opioid treatment for chronic low back pain (cLBP) with some interesting phase 1b data.
Chronic low back pain is a problem that affects millions of people, many of whom aren’t helped by existing treatments. Persica’s drug aims to be the first approved pharmaceutical to target cLBP as ...
Keywords
biotechbiotechnologyCRISPRCaszymeLithuaniaPersica Pharmaceuticalsback painchronic low back pain